Page last updated: 2024-09-03

cp 115953 and pd-117596

cp 115953 has been researched along with pd-117596 in 1 studies

Compound Research Comparison

Studies
(cp 115953)
Trials
(cp 115953)
Recent Studies (post-2010)
(cp 115953)
Studies
(pd-117596)
Trials
(pd-117596)
Recent Studies (post-2010) (pd-117596)
20002100

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aldous, SC; Coughlin, SA; Dorff, PH; Gruett, MD; Lesher, GY; Rake, JB; Reuman, M; Singh, B; Wentland, MP1

Other Studies

1 other study(ies) available for cp 115953 and pd-117596

ArticleYear
Mammalian topoisomerase II inhibitory activity of 1-cyclopropyl-6,8- difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarb oxylic acid and related derivatives.
    Journal of medicinal chemistry, 1993, Sep-17, Volume: 36, Issue:19

    Topics: Animals; Anti-Infective Agents; Fluoroquinolones; HeLa Cells; Humans; Leukemia P388; Mice; Quinolones; Structure-Activity Relationship; Topoisomerase II Inhibitors

1993